Registration for a live webinar on 'Innovations in antibiotic discovery: combating resistant infections' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Evolutionary Perspectives
-
1. Antibiotic resistance: a mechanistic overview
- Dr. Neil Woodford
-
2. Mutation
- Prof. Stephen Gillespie
-
3. Fitness in antibiotic resistant bacteria
- Prof. Stephen Gillespie
-
4. Fitness and compensation
- Dr. Sébastian Gagneux
-
5. Antibiotic resistance and the supragenome hypothesis
- Dr. Bambos Charalambous
- Epidemiology and Clinical Impact
-
6. Methicillin resistant S. aureus and other resistances
- Prof. Mark Enright
-
7. Risk factors for antibiotic resistance in Streptococcus pneumoniae
- Prof. Keith Klugman
-
8. Beta-lactamases: clinical impact and epidemiology
- Prof. Sebastian Amyes
-
9. Glycopeptide-resistant enterococci
- Dr. Neil Woodford
-
10. Drug resistant tuberculosis: biology, epidemiology and control
- Dr. Christopher Dye
-
11. Antiretroviral drug resistance
- Prof. Deenan Pillay
-
12. Malaria - changing paradigms
- Dr. Janet Cox-Singh
-
13. Advances in mode of action of antimalarials and resistance mechanisms 1
- Prof. David Warhurst
-
14. Advances in mode of action of antimalarials and resistance mechanisms 2
- Prof. David Warhurst
-
15. HCV resistance
- Prof. John Dillon
- Diagnosis and Surveillance of Resistance
-
16. Conventional and automated diagnostic methods
- Dr. Alan Johnson
-
17. National and international surveillance of antibiotic resistance 1
- Prof. David Livermore
-
18. National and international surveillance of antibiotic resistance 2
- Prof. David Livermore
-
19. Innovative approaches to rapid antibiotic resistance testing
- Dr. Robert Hammond
- Controlling Antibiotic Resistance
-
20. Controlling antibiotic resistance in the hospital environment
- Dr. Ian Eltringham
-
21. Controlling antibiotic resistance in the community
- Dr. Peter Wilson
-
22. Public policy to reduce antibiotic resistance
- Dr. Niels Frimodt-Møller
- The Antibiotic Resistance Future
-
23. Overcoming resistance through novel drug targets
- Prof. Anthony Coates
-
24. Medicinal chemistry strategies in combating antibiotic resistance
- Dr. Geoffrey Coxon
-
25. Teixobactin kills pathogens without detectable resistance
- Prof. Kim Lewis
- Archived Lectures *These may not cover the latest advances in the field
-
26. Molecular diagnosis of antibiotic resistance
- Dr. Tim McHugh
-
27. Introduction to malaria
- Prof. David Warhurst
Printable Handouts
Navigable Slide Index
- Introduction
- Factors to study in the evolution of resistance
- Antibiotic resistance by chromosomal mutation
- Mutation
- Likelihood of resistance emerging
- Diagram - a "jackpot" culture
- Diagram - a late mutation
- Diagram - which has the highest mutation rate?
- Mutation rate and mutation frequency - summary
- Determining mutation rate
- Overview on mutation rate experiments (1)
- Overview on mutation rate experiments (2)
- Range of detected mutations in an experiment
- MICs of different mutant strains of S. pneumoniae
- Parameters for planning mutation rate experiments
- Methods of calculation of mutation rates
- Variables for the calculation of mutation rate
- Equations used in the calculation of m
- Calculating mutation rate
- What do we mean by mutation rate?
- Assumptions in a fluctuation analysis
- Does cell state affect the mutation rate?
- No increase in mutation rate in low pH
- Chemostat at pH=7
- Chemostat at pH=6.2
- Hypermutability
- Rifampicin mutation frequency in CF patients
- Antibiotic resistance in CF patients
- Mutator strains belonging to E. coli and Shigella
- Mutator strains more likely to generate resistance
- Identifying mutator strains
- Mutation rates for first- and second-step mutants
- Antibiotics can increase mutation rate
- Case report of antibiotic resistance
- Reservoir of mutants in untreated patients
- Mutations in gyrA, parC
- Summary
Topics Covered
- Factors to study in the evolution of resistance
- Antibiotic resistance by chromosomal mutation
- Likelihood of resistance emerging
- Determining mutation rate
- Parameters for planning a mutation rate experiment
- Methods of calculating mutation rate
- Assumptions in a fluctuation analysis
- Environmental stresses in the host environment
- Hypermutability
Talk Citation
Gillespie, S. (2010, January 13). Mutation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved May 8, 2025, from https://doi.org/10.69645/NLWY7843.Export Citation (RIS)
Publication History
- Published on January 13, 2010
Financial Disclosures
- Prof. Stephen Gillespie is in receipt of research grants from MMRC, EDCTP, Global Alliance for TB Drug Development. Professor Gillespie’s involvements in clinical trials are supported by active and placebo drug supplies from Bayer Schering Health Care and Sanofi Aventis, while also providing support with regulatory and drug safety advice. Neither company has a managerial role within the study, however. Professor Gillespie has also provided training to senior staff at Bayer Schering Health Care.